There is a major reduction in respiratory competence, and inhibition of growth, several hours after the addition of erythromycin or chloramphenicol to Saccharomyces cerevisiae growing in medium containing a non-fermentable carbon source. Spectrographic evidence is presented for a loss of cytochrome oxidase as a consequence of the antibiotic treatment. This loss is prevented by cyanide or oligomycin. When glucose is added, however, the loss occurs irrespective of the presence of the respiratory inhibitors. Cycloheximide does not affect respiratory competence or cause loss of cytochrome oxidase, and it prevents the loss elicited by erythromycin if both compounds are added together. However, if cycloheximide is added some time after the addition of erythromycin, it fails to block the response to the latter drug. The results cannot be accounted for on the basis of the segregation of a finite number of mitochondria into an increasing number of progeny cells but, rather, suggest that the mitochondria are modified during growth in chloramphenicol or erythromycin.
I N T R O D U C T I O N
The antibiotics chloramphenicol and erythromycin specifically inhibit protein synthesis in bacteria, mitochondria and chloroplasts by interference with the ribosomes, while the cytoplasmic ribosomes of eukaryotes are resistant to these drugs (Wintersberger, 1965 ; Lamb, Clark-Walker & Linnane, 1968; Borst & Grivell, 1971) . Such agents inhibit the growth of the facultative anaerobe Saccharomyces cerevisiae growing aerobically on nonfermentable substrates (e.g. glycerol) , that is when using the mitochondrial respiratory system, but do not inhibit growth on fermentable substrates (e.g. glucose). We studied events leading to the arrest of growth of this organism in a glycerol medium containing one or other of these antibiotics. Both compounds prevent the synthesis of cytochrome oxidase (cytochrome aa,) and cytochrome b (Tzagoloff, Rubin & Sierra, 1973; Mahler & Perlman, 1971) , but the fate of the pre-existing cytochromes when mitochondria1 protein synthesis is blocked has not been considered. We present evidence that under these conditions cytochrome oxidase is lost and there is a drop in respiratory competence.
I % (w/v) NaCl, mixed with about 10 mg sodium dithionite as reducing agent, and suspended in distilled water to a final volume of 1-3 ml. Absorption spectra were obtained at room temperature, using a Unicam SP I 800 recording spectrophotometer. To obtain an approximate estimate of changes in the relative amounts of cytochromes, the areas of the different absorption peaks were related by weighing copies on heavy tracing fabric of the areas. In general, the cytochrome c peak and its shoulder, representing cytochrome b, were weighed together. In some experiments, washed cells were first resuspended in tris-HCl buffer (0.05 M, pH 8.0) containing glycerol (15 %, w/v), then frozen in dry ice -acetone and broken by crushing in a pre-cooled Eaton press (Eaton, 1962) in order to exclude the possibility that dithionite was penetrating inefficiently and, therefore, failing completely to reduce the cytochromes.
Measurement of respiratory activity. Intact, washed cells from 10 ml culture were resuspended at about Io6/ml in sodium phosphate buffer (0.1 mM, pH 6.8) containing sodium succinate (0.5 mM), a substrate readily available to intact yeast cells (Hughes & Wilkie, 1970) . Cyanide-sensitive oxygen uptake (50 pg KCN/ml) was measured polarographically in a Clark-type oxygen electrode coupled to a pen recorder.
Cell viability. Colony-forming units were compared with total cells plated, as measured in the haemocytometer.
R E S U L T S
Eflect of erythromycin and chloramphenicol on growth, respiratory competence and cytochrorne absorption spectrum When either antibiotic was added at I mg/ml to yeast growing in a glycerol medium, growth continued at approximately the normal rate for 5 h, slowed down over the next 3 h, then stopped; the cell mass increased by a factor of about 2.5 (Table I) . Respiratory competence, measured as the rate of oxygen uptake using a series of equal culture volumes, greatly decreased (Table I) . Spectra of suspensions of intact cells, derived from a series of equal volumes of culture taken at various times during these experiments, showed that in the presence of the drugs there was a fall in the characteristic absorption peak of cytochrome oxidase at 605 nm. After a somewhat variable time (10 to 20 h), this peak had virtually disappeared ( Table I) . The same results were obtained in several independent experiments. There was no induction of the petite condition, i.e. mitochondria1 mutation to respiratory deficiency. This is in contrast to the result of erythromycin or chloramphenicol treatment in fermentable medium, where growth continues and petite mutants appear after several generations (Williamson, Maroudas & Wilkie, 1 9 7 1). Cell viability was unaffected during the course of the present experiments.
A series of absorption spectra demonstrated that the loss of cytochrome oxidase was gradual and began soon after the addition of erythromycin (Fig. I) . The decrease in the 605 nm absorption peak was not due to a failure of sodium dithionite to penetrate efficiently, because identical spectra were observed when cells were broken with an Eaton press before the addition of this compound. The absorption of cytochrome b at 561 nm was difficult to measure due to its overlap with the relatively large, and increasing, cytochrome c peak at 550 nm, but it is evident from Fig. I (and from Fig. 2 The budding of individual cells micromanipulated on to agar with or without erythromycin (I mg/ml) was studied. The first bud appeared after about 2 h, whether the drug was present or not. However, second-generation buds were significantly slower to develop in the presence of the drug, and on average only one more daughter cell was produced, resulting in clones of about five cells. These cells usually remained attached to the parent cell and the later-formed buds tended to be relatively small. This result is in tolerable agreement with growth measurements in liquid medium.
Eflect of cycloheximide
Cycloheximide blocks cytoplasmic protein synthesis in eukaryotes due to its affinity for cytoplasmic ribosomes ; it has no direct effect on mitochondria1 protein synthesis (Lamb et al. 1968) . When this drug (at 50 ,ug/ml, as in Table I , or at 300 ,ug/ml) was used in place of erythromycin in experiments similar to that described above, the extinction of the culture increased by 50 %during the first 6 h. This was the result of cell swelling rather than budding; microscopy showed that budding was totally blocked by cycloheximide. However, the inhibition of cytoplasmic protein synthesis reduced respiratory competence by a mere 33 % over 40 h (although the cells were dead by then), and the cytochrome spectrum was virtually unchanged.
Eflect of addition of cycloheximide during erythromycin treatment If erythromycin and cycloheximide were added together, the loss of the cytochromeoxidase spectrum normally elicited by the former drug (Fig. 2F) did not occur (Fig. zB) , and respiratory competence fell by only 32 % over 15 h. However, if the culture was inhibited for a short period by erythromycin alone, then cycloheximide did not prevent the subsequent disappearance of the 605 nm absorption peak. A delay of 0.5 to I -5 h (Fig. 2 C,D) before the addition of cycloheximide permitted some reduction during the ensuing 14 h, and a delay of 3 h allowed its complete loss (Fig. 2E) , accompanied by an 86 % drop in respiratory competence. In these three cultures, material absorbing maximally at 580 nm appeared, and was quite distinct from the cytochrome-oxidase maximum. The nature and origin of this product are unknown.
Effect of glucose, oligomycin and cyanide
To see whether the effect of erythromycin was caused merely by a drop in the amount of available energy, glucose (to 0.2 % final concentration) was added initially to the glycerol medium and added subsequently every 4 h. This was found to maintain growth in the presence of erythromycin. Glycolysis is known to provide adequate intramitochondrial ATP to maintain, for example, mitochondrial nucleic acid synthesis in respiration-deficient petite mutants (Borst, I 972), and mitochondrial DNA replication proceeds for several generations in yeast growing in glucose medium in the presence of erythromycin (Williamson et aE. 1971) . In control cultures containing this low glucose concentration, the growth rate, cytochrome content and respiratory activity were comparable to those in cultures with glycerol alone (Table 2 ; compare with Table I ). Although glucose permitted the cells to continue dividing in the presence of erythromycin, it was found that a fall in respiratory competence and a loss of the cytochrome-oxidase spectrum took place, as in the absence of glucose (Table 2) . Furthermore, in the absence of glucose, if, instead of adding erythromycin, the supply of ATP was blocked by 10 pg oligomycin/ml or 50 pg cyanidelml, the cytochrome-oxidase peak persisted (Table 3 ). This Table also shows that cyanide prevented the loss of the cytochrome-oxidase spectrum normally caused by erythromycin. However, when 0-2 % glucose was also present, the cells were able to grow and the cytochrome peak disappeared. With cyanide, erythromycin and glucose, the loss of cytochrome oxidase was prevented by the addition of cycloheximide at zero time. This series of experiments suggests that the loss of cytochrome oxidase depends on respiration only inasmuch as this is a requirement for cytoplasmic protein synthesis if no fermentable substrate is present. * Relative areas of absorption peaks.
Loss of cytochrome oxidase in yeast I55

D I S C U S S I O N
Drugs which are known specifically to block mitochondrial protein synthesis (see Stone & Wilkie, I 974), when added to yeast metabolizing a non-fermentable substrate, stopped growth after one or two cell divisions, while there was a dramatic reduction in the ability to take up oxygen. This cannot be explained by the segregation of a finite number of mitochondria into an increasing number of cells. Our data suggest, rather, that these effects can be accounted for by a loss of cytochrome oxidase, the terminal component of the respiratory chain. Preliminary evidence from electron microscopy indicates accompanying degradative changes in mitochondrial inner membrane structure.
Mitochondria1 protein synthesis is required for the assembly of at least four structures which form an integral part of the mitochondrion's inner membrane. These include cytochrome oxidase, three of whose seven polypeptide subunits are made on the mitochondrial ribosomes (Tzagoloff et al. 1973; Mason & Schatz, I973) , as well as cytochrome b (Mahler & Perlman, I 97 I), and oligomycin-sensitive ATPase (Tzagoloff et al. 1973) . Other proteins may also be involved. Cytochrome c is manufactured by the cytoplasmic system (Sherman, Taber & Campbell, 1965) . This explains why erythromycin and chloramphenicol block the formation of cytochrome oxidase and cytochrome b while permitting an increase in cytochrome c. But it is difficult to see why this should lead to the disappearance of the preexisting cytochrome oxidase. If the phenomenon reflects protein turnover in the inhibited mitochondrion, it does not result merely from an insufficiency of energy for normal maintenance because it is just as pronounced when erythromycin is added in the presence of glucose, which supplies adequate intra-mitochondria1 ATP for macromolecular synthesis (Williamson et al. 1971 ; Borst, 1972) . Turnover of cytochrome oxidase may nevertheless be involved, and its prevention by cycloheximide may indicate the need for the synthesis of a labile peptidase, as proposed for tyrosine transaminase turnover in rat liver (Kenney, I 967) . However, cycloheximide does not prevent the loss of cytochrome oxidase if it is added 2 to 3 h after the addition of erythromycin. This suggests that either the relevant cytoplasmic proteins, once made, persist, or they initially modify the environment of cytochrome oxidase so that it becomes susceptible to other factors.
